General Information of the Compound
| Compound ID |
CP0564397
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-chloro-9-oxoindeno[1,2-b]pyrazine-2,3-dicarbonitrile
Show/Hide
|
||||||||||||||||||
| Synonyms |
HBX-41108
USP inhibitors (cancer), Hybrigenics
USP-7 inhibitors (cancer), Hybrigenics
USP-7 inhibitors, Hybrigenics
USP-9 inhibitors (cancer), Hybrigenics
Ubiquitin-specific protease inhibitors (cancer), Hybrigenics
Ubiquitin-specific protease-7 inhibitors (cancer), Hybrigenics
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H3ClN4O
|
||||||||||||||||||
| Molecular Weight |
266.647
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc-2c(c1)C(=O)c1nc(C#N)c(nc-21)C#N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H
Show/Hide
|
||||||||||||||||||
| InChIKey |
BIGPXXAUSQLTQR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Clinical Information about the Compound